Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2009
08/06/2009WO2009095438A1 Novel aryl piperazine derivatives useful as modulators of dopamine and serotonin receptors
08/06/2009WO2009095437A1 Use of eicosapentaenoic acid and/or docosahexahenoic acid in women with endometriosis
08/06/2009WO2009095431A1 Novel salts of o-desmethyl-venlafaxine
08/06/2009WO2009095418A1 Use of ulipristal for treating uterine fibroids
08/06/2009WO2009095399A2 Pyrazine derivatives and their use as protein kinase inhbitors
08/06/2009WO2009095395A2 Pharmaceutical compositions
08/06/2009WO2009095394A1 Diazepanes as histamine h3 receptor antagonists
08/06/2009WO2009095387A1 Use of inhibitor of beta-lactamases and its combination with beta-lactam antibiotics
08/06/2009WO2009095378A1 Use of hedgehog agonists in the treatment of musculoskeletal-related disorders
08/06/2009WO2009095377A1 Spiro compounds as npy y5 receptor antagonists
08/06/2009WO2009095324A1 Novel n-(2-amino-phenyl)-amide derivatives
08/06/2009WO2009095269A1 Use of tetrahydropyrimidines
08/06/2009WO2009095254A1 Pyrazolopyrimidines, a process for their preparation and their use as medicine
08/06/2009WO2009095253A1 6-halo-pyrazolo[1, 5-a]pyridines, a process for their preparation and their use as metabotropic glutamate receptor (mglur) modulators
08/06/2009WO2009095240A1 Methods and compositions for the treatment of bone conditions
08/06/2009WO2009095210A1 Composition comprising an antacid and a h2-antagonists
08/06/2009WO2009095163A2 Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals
08/06/2009WO2009095162A1 Cyclic azaindole-3-carboxamides, their preparation and their use as pharmaceuticals
08/06/2009WO2009095028A1 Ointment on the basis of a dialysate of calves' blood.
08/06/2009WO2009094958A1 Saccharide lupane derivatives, their use and pharmaceutical compositions containing these derivatives
08/06/2009WO2009094866A1 Dicycloazaalkane derivates, preparation processes and medical uses thereof
08/06/2009WO2009094845A1 5-(3-heteroaromatic ring substituted phenyl) tetrazole compounds and their uses for anti-hiv/aids
08/06/2009WO2009094831A1 Heteroaromatic compounds, the preparation method and the use thereof
08/06/2009WO2009094811A1 A royal jelly acidic mixture preparation and application thereof
08/06/2009WO2009094807A1 Compounds from mycelium of antrodia cinnamomea and use thereof
08/06/2009WO2009094750A1 Fast dissolution amino acid composition
08/06/2009WO2009094730A1 Vaccine compositions
08/06/2009WO2009094718A1 Methods of treating thromboembolic disorders
08/06/2009WO2009075841A3 Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of antecedent hematologic disorders
08/06/2009WO2009074950A3 Thiophene derivatives as agonists of s1p1/edg1
08/06/2009WO2009074853A3 Ophthalmic composition comprising phenylephrine
08/06/2009WO2009074811A3 Use of 5-aminolevulinic acid and derivatives in a solid form for photodynamic treatment and diagnosis
08/06/2009WO2009073146A3 Use of immunomodulatory compounds for the treatment of transverse myelitis, multiple sclerosis, and other disorders
08/06/2009WO2009069032A3 Novel glucocorticoid receptor agonists
08/06/2009WO2009068689A3 Combination of protein tyrosine phosphatase inhibitors and human growth hormone for the treatment of muscle atrophy and related disorders
08/06/2009WO2009067317A3 Use of levocabastine for modulating generation of pro- inflammatory cytokines
08/06/2009WO2009065126A3 Excipients for protein stabilization
08/06/2009WO2009064938A9 Method of treating arthritis
08/06/2009WO2009063495A3 Substituted indole and its derivatives as cannabinoid modulators
08/06/2009WO2009062082A3 Selective estrogen receptor modulator compositions and methods for treatment of disease
08/06/2009WO2009060452A3 Methods and compositions for treating biliary cholesterol crystallization and related conditions
08/06/2009WO2009059304A3 Compounds for treating abnormal cellular proliferation
08/06/2009WO2009056266A3 Candesartan cilexetil
08/06/2009WO2009054952A3 Small molecule inhibitors of parp activity
08/06/2009WO2009053999A3 Sulfoximine derivatives as factor xa inhibitors
08/06/2009WO2009053750A3 Novel crystalline and amorphous forms
08/06/2009WO2009053424A9 Crystalline salt of montelukast
08/06/2009WO2009052353A3 Trospium pharmaceutical formulations
08/06/2009WO2009051840A3 Compositions and methods for reducing hepatotoxicity associated with drug administration
08/06/2009WO2009048760A3 Biphenyl inhibitors of carbonyl reductase
08/06/2009WO2009047791A3 Toll like receptor (tlr) signaling antagonist
08/06/2009WO2009044251A3 Hydrocortisone derivatives and use thereof for therapeutic or cosmetic indications
08/06/2009WO2009040702A3 Pharmaceutical compositions of rhein or diacerein
08/06/2009WO2009024585A3 Imidazo [1,2-a] pyrazine compounds for treatment of viral infections such as hepatitis
08/06/2009WO2009023179A3 Nitrogen containing bicyclic chemical entities for treating viral infections
08/06/2009WO2009017803A8 Antisense microrna and uses therefor
08/06/2009WO2009011870A8 Reduction of beta-amyloid levels by treatment with the small molecule differentiation-inducing factor
08/06/2009WO2009007853A3 Novel polymorphs of darifenacin free base and its hydrobromide salt
08/06/2009WO2009007764A3 Pharmaceutical preparations containing highly volatile silicones
08/06/2009WO2009004152A3 Use of a composition of oligomers of galacturonic acid as an agent for inhibiting degradation of collagen
08/06/2009WO2009004085A3 Dsrna for treating viral infection
08/06/2009WO2008150957A3 Treatment of imatinib resistant leukemia using 4-aminoquinoline-3-carbonitriles
08/06/2009WO2008132500A3 Chkl inhibitors with b cell depleting antibodies for the treatment of hematologic malignancies
08/06/2009WO2008124102A3 Ara-c in combination with a cytokine-secreting cell and use thereof
08/06/2009WO2008116890A3 Pharmaceutical compositions comprising flibanserin and a further agent in the treatment of sexual disorders
08/06/2009WO2008109532A8 Nucleic acid compounds for inhibiting fas gene expression and uses thereof
08/06/2009WO2008109382A8 Nucleic acid compounds for inhibiting pkn3 gene expression and uses thereof
08/06/2009WO2008100450A4 Therapeutic effects of bryostatins, bryologs, and other related substances on ischemia/stroke-induced memory impairment and brain injury
08/06/2009WO2008092099A8 Compositions and methods for treating hematopoietic malignancies
08/06/2009WO2008073961A8 Compounds and methods for modulating the silencing of a polynucleotide of interest
08/06/2009WO2002102301A3 Substituted indole-2-carboxylic acid benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof
08/06/2009US20090198145 Compositions, methods, and systems for rapid induction and maintenance of continuous rem sleep
08/06/2009US20090198063 Novel heterocyclic compound or salt thereof and intermediate thereof
08/06/2009US20090198061 Camptothecin analogs and methods of preparation thereof
08/06/2009US20090197976 Treatment and composition for achieving skin anti-aging benefits by corneum protease activation
08/06/2009US20090197971 Method for Improving Flavor of Astaxanthin-Containing Extract
08/06/2009US20090197970 Crystalline form of cinacalcet
08/06/2009US20090197969 Method of reducing brain cell damage or death
08/06/2009US20090197968 Extended-release capsules comprising venlafaxine hydrochloride
08/06/2009US20090197967 Compositions and methods for treatment of ophthalmic diseases and disorders
08/06/2009US20090197966 Use of Hypothermia Inducing Drugs
08/06/2009US20090197965 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
08/06/2009US20090197964 Methods and compositions for treatment for coronary and arterial aneurysmal subarachnoid hemorrhage
08/06/2009US20090197963 Method and compositions for suppressing appetite or treating obesity
08/06/2009US20090197962 Substituted cyclopentanes having prostaglandin activity
08/06/2009US20090197961 Diclofenac Formulations and Methods of Use
08/06/2009US20090197960 Method of Inhibiting Polyneuropathic Pain with 3-(2-Dimethylaminomethylcyclohexyl) Phenol
08/06/2009US20090197959 N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
08/06/2009US20090197958 Sustained Release Particulate Oral Dosage Forms of (R) Baclofen and Methods of Treatment
08/06/2009US20090197957 Methods and compositions for the treatment of pain
08/06/2009US20090197956 Treatment of acute otitis media with xylitol and n-acetylcysteine
08/06/2009US20090197955 Methods of improving dha deposition and related function and/or development
08/06/2009US20090197954 Linoleic acid preparations for the topical treatment of male and female pattern androgenetic alopecia, age-related alopecia, and keratosis pilaris
08/06/2009US20090197953 Pharmaceutical composition for the specific treatment of acute myeloid leukemia
08/06/2009US20090197952 Glyceride Esters for the Treatment of Diseases Associated with Reduced Neuronal Metabolism of Glucose
08/06/2009US20090197951 Substituted Fullerene Formulations and Their Use in Ameliorating Oxidative Stress Diseases or Inhibiting Cell Death
08/06/2009US20090197950 Substituted Fullerenes and Their Use as Inhibitors of Cell Death
08/06/2009US20090197949 Antitumor methods and compositions comprising sesquiterpene derivatives
08/06/2009US20090197948 Skin External Preparation
08/06/2009US20090197947 Medicaments and methods for lowering plasma lipid levels and screening drugs
1 ... 2630 2631 2632 2633 2634 2635 2636 2637 2638 2639 2640 2641 2642 2643 2644 2645 2646 2647 2648 2649 2650 ... 7860